About POCT
POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients' quality of life.
TechNavio's analysts forecast the POCT market in China to grow at a CAGR of 20.69 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the POCT market in China for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the following applications of POCT:
• Blood glucose testing
• Cholesterol testing
• Infectious disease testing
• Blood gas testing
• Cardiac biomarkers testing
• Pregnancy testing
• Others (such as cancer biomarker, electrolyte analyzers, blood coagulation testing, tumor marker, and urinalysis testing)
TechNavio's report, the POCT Market in China 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers China; it also covers the landscape of the POCT market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Region
• China
Key Vendors
• Abbott Laboratories
• Bayer HealthCare
• F. Hoffmann-La Roche
• LifeScan
Other Prominent Vendors
• Bioptik Technology
• Chongqing Haray International Business
• Fudakang Ind'l
• Guangzhou Maya Medical Equipment
• Jiangxi Zhongchenda Industrial Investment
• Nantong Voyage International Trade
• Shenzhen Fitconn Technology
• Shiny Health Import & Export
• Sunrising Enterprise
• Wuhan HNC Technology
• Yuan Yu Bio-Tech
Market Driver
• Technological Innovations
• For a full, detailed list, view our report
Market Challenge
• Advances in Technology
• For a full, detailed list, view our report
Market Trend
• Expanding Economy of China
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Application
07.1 Blood Glucose Testing Market in China
07.1.1 Market Size and Forecast
07.2 Cholesterol Testing Market in China
07.2.1 Market Size and Forecast
07.3 Infectious Disease Testing Market in China
07.3.1 Market Size and Forecast
07.4 Blood Gas Testing Market in China
07.4.1 Market Size and Forecast
07.5 Cardiac Biomarkers Testing Market in China
07.5.1 Market Size and Forecast
07.6 Pregnancy Testing Market in China
07.6.1 Market Size and Forecast
08. Market Segmentation by Technology
08.1 Electrochemical Biosensors
08.2 Optical Biosensors
08.3 Piezoelectric Biosensors
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.2 Market Share Analysis 2013
16.3 Other Prominent Vendors
16.4 Abbott Laboratories
16.4.1 Key Facts
16.4.2 Business Overview
16.4.3 Business Segmentation by Revenue 2012
16.4.4 Business Segmentation by Revenue 2011 and 2012
16.4.5 Geographical Segmentation by Revenue 2012
16.4.6 Business Strategy
16.4.7 Key Information
16.4.8 SWOT Analysis
16.4.9 Strengths
16.4.10 Weakness
16.4.11 Opportunities
16.4.12 Threats
16.5 Bayer HealthCare
16.5.1 Key Facts
16.5.2 Business Overview
16.5.3 Business Segmentation by Revenue 2013
16.5.4 Business Segmentation by Revenue 2012 and 2013
16.5.5 Geographical Segmentation by Revenue 2013
16.5.6 Business Strategy
16.5.7 Recent Developments
16.5.8 SWOT Analysis
16.5.9 Strengths
16.5.10 Weaknesses
16.5.11 Opportunities
16.5.12 Threats
16.6 LifeScan
16.6.1 Key Facts
16.6.2 Business Overview
16.6.3 Product Segmentation
16.6.4 Geographical Segmentation by Revenue 2013
16.6.5 Business Strategy
16.6.6 Recent Developments
16.6.7 SWOT Analysis
16.6.8 Strengths
16.6.9 Weaknesses
16.6.10 Opportunities
16.6.11 Threats
16.7 F. Hoffmann La Roche
16.7.1 Key Facts
16.7.2 Business Overview
16.7.3 Business Segmentation by Revenue 2013
16.7.4 Business Segmentation by Revenue 2012 and 2013
16.7.5 Sales by Geography 2013
16.7.6 Business Strategy
16.7.7 Recent Developments
16.7.8 SWOT Analysis
16.7.9 Strengths
16.7.10 Weaknesses
16.7.11 Opportunities
16.7.12 Threats
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: POCT market in China 2013-2018 (US$ million)
Exhibit 3: POCT Market in China Segmentation by Application
Exhibit 4: POCT Market in China Segmentation by Application 2013
Exhibit 5: Blood Glucose Testing Market in China 2013-2018 (US$ million)
Exhibit 6: Cholesterol Testing Market in China 2013-2018 (US$ million)
Exhibit 7: Infectious Disease Testing Market in China 2013-2018 (US$ million)
Exhibit 8: Blood Gas Testing Market in China 2013-2018 (US$ million)
Exhibit 9: Cardiac Biomarkers Testing Market in China 2013-2018 (US$ million)
Exhibit 10: Pregnancy Testing Market in China 2013-2018 (US$ million)
Exhibit 11: POCT market in China Segmentation by Application 2013-2018
Exhibit 12: POCT Market Segmentation by Technology in China
Exhibit 13: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 14: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 15: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 16: Bayer Healthcare: Business Segmentation by Revenue 2013
Exhibit 17: Bayer Healthcare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 18: Bayer Healthcare: Geographical Segmentation by Revenue 2013
Exhibit 19: LifeScan: Product Segmentation 2013
Exhibit 20: LifeScan: Geographical Segmentation by Revenue 2013
Exhibit 21: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 22: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 23: F. Hoffmann-La Roche: Sales of Pharmaceuticals Division by Geography 2013
Exhibit 24: F. Hoffmann-La Roche: Sales of Diagnostics Division by Geography 2013
